Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)

The REGAIN Study Group

    Research output: Contribution to journalComment/debatepeer-review

    Fingerprint

    Dive into the research topics of 'Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Social Sciences